Connect public, paid and private patent data with Google Patents Public Datasets

A protective sheath apparatus and method for use with a heart wall actuation system for the natural heart

Info

Publication number
WO2004008941A2
WO2004008941A2 PCT/US2003/022054 US0322054W WO2004008941A2 WO 2004008941 A2 WO2004008941 A2 WO 2004008941A2 US 0322054 W US0322054 W US 0322054W WO 2004008941 A2 WO2004008941 A2 WO 2004008941A2
Authority
WO
Grant status
Application
Patent type
Prior art keywords
heart
wall
actuator
sheath
protective
Prior art date
Application number
PCT/US2003/022054
Other languages
French (fr)
Other versions
WO2004008941A3 (en )
Inventor
David Boyd Melvin
Original Assignee
The University Of Cincinnati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/10Blood pumps; Artificial hearts; Devices for mechanical circulatory assistance, e.g. intra-aortic balloon pumps
    • A61M1/1037Pumps having flexible elements, e.g. with membranes, diaphragms, or bladder pumps
    • A61M1/1067Pumps having flexible elements, e.g. with membranes, diaphragms, or bladder pumps using a blood vessel as flexible element
    • A61M1/1068Pumps having flexible elements, e.g. with membranes, diaphragms, or bladder pumps using a blood vessel as flexible element using the heart as flexible element
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/10Blood pumps; Artificial hearts; Devices for mechanical circulatory assistance, e.g. intra-aortic balloon pumps
    • A61M1/1037Pumps having flexible elements, e.g. with membranes, diaphragms, or bladder pumps
    • A61M1/1046Drive systems therefor, e.g. mechanically, electromechanically or skeletal muscle drive means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/10Blood pumps; Artificial hearts; Devices for mechanical circulatory assistance, e.g. intra-aortic balloon pumps
    • A61M1/1037Pumps having flexible elements, e.g. with membranes, diaphragms, or bladder pumps
    • A61M1/1046Drive systems therefor, e.g. mechanically, electromechanically or skeletal muscle drive means
    • A61M1/1053Drive systems therefor, e.g. mechanically, electromechanically or skeletal muscle drive means using non-rotary electrical means
    • A61M1/1056Thermo-electric means, e.g. shaped memory alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/10Blood pumps; Artificial hearts; Devices for mechanical circulatory assistance, e.g. intra-aortic balloon pumps
    • A61M1/12Blood pumps; Artificial hearts; Devices for mechanical circulatory assistance, e.g. intra-aortic balloon pumps implantable into the body

Abstract

An actuation system (82) for assisting the operation of the natural heart includes a framework (70) for interfacing with a natural heart and which is coupled with tissue of the heart. An actuator element (86) is adapted to be coupled to the framework (70) and is configured for extending along a portion of a heart wall exterior surface. The actuator element (86) is operable for deforming the portion of the heart wall to effect a reduction in the volume of the heart. A protective sheath (84) is configured to extend along the heart wall between the actuator element and the heart wall portion for protecting the heart wall portion from damage by the actuator element. The protective sheath (84) is flexible and operable to transmit, to the heart wall portion, a force thereon by the actuator element (86) for indenting the heart wall portion.

Description

A PROTECTIVE SHEATH APPARATUS AND METHOD FOR USE WITH A HEART WALL ACTUATION SYSTEM FOR THE NATURAL HEART

Related Applications

This application is related to an application entitled "A Flexible, Torsionable Cardiac Framework for Heart Wall Actuation of the Natural Heart, filed on even date herewith, which is incorporated herein by reference in its entirety. Field of the Invention

This invention relates generally to assisting the natural heart in operation by actuating a wall of the natural heart, and more specifically to facilitating such actuation without damage to the heart tissue.

Background of the Invention

The natural human heart and accompanying circulatory system are critical components of the human body and systematically provide the needed nutrients and oxygen for operation of the body. As such, the proper operation of the circulatory system, and particularly, the proper operation of the heart, are critical in the life, health and well-being of a person. A physical ailment or condition which compromises the normal and healthy operation of the heart can therefore be particularly critical and may result in a condition which must be medically remedied.

More specifically, the natural heart, or rather the cardiac tissue of the heart, can degrade for various reasons to a point where the heart can no longer provide sufficient circulation of blood for maintaining the health of a patient at a desirable level. In fact, the heart may degrade to the point of failure and thereby may not even be able to sustain life. To address the problem of a failing natural heart, solutions are offered to provide ways in which circulation of blood might be maintained. Some solutions involve replacing the heart. Other solutions are directed to maintaining operation of the existing heart. One such solution has been to replace the existing natural heart in a patient with an artificial heart or a ventricular assist device. In using artificial hearts and/or assist devices, a particular problem stems from the fact that the materials used for the interior lining of the chambers of an artificial heart are in direct contact with the circulating blood. Such contact may enhance undesirable clotting of the blood, may cause a build-up of calcium, or may otherwise inhibit the blood's normal function. As a result, thromboembolism and hemolysis may occur. Additionally, the lining of an artificial heart or a ventricular assist device can crack, which inhibits performance, even when the crack is at a microscopic level. Such drawbacks have limited the use of artificial heart and assist devices to applications having too brief of a time period to provide a real lasting health benefit to the patient.

An alternative procedure also involves replacement of the heart, but includes a transplant of a natural heart from another human or animal into the patient. The transplant procedure requires removing an existing organ

(i.e. the natural heart) from the patient for substitution with another organ (i.e. another natural heart) from another human, or potentially, from an animal. Before replacing an existing organ with another, the substitute organ must be "matched" to the recipient, which can be, at best, difficult, time consuming, and expensive to accomplish. Furthermore, even if the transplanted organ matches the recipient, a risk exists that the recipient's body will still reject the transplanted organ and attack it as a foreign object. Moreover, the number of potential donor hearts is far less than the number of patients in need of a natural heart transplant. Although use of animal hearts would lessen the problem of having fewer donors than recipients, there is an enhanced concern with respect to the rejection of the animal heart.

Rather than replacing the patient's heart, other solutions attempt to continue to use the existing heart and associated tissue. In one such solution, attempts have been made to wrap skeletal muscle tissue around the natural heart to use as an auxiliary contraction mechanism so that the heart may pump. As currently used, skeletal muscle cannot alone typically provide sufficient and sustained pumping power for maintaining circulation of blood through the circulatory system of the body. This is especially true for those patients with severe heart failure. Another system developed for use with an existing heart for sustaining

the circulatory function and pumping action of the heart, is an external bypass system, such as a cardiopulmonary (heart-lung) machine. Typically, bypass systems of this type are complex and large, and, as such, are limited to short term use, such as in an operating room during surgery, or when maintaining the circulation of a patient while awaiting receipt of a transplant heart. The size and complexity effectively prohibit use of bypass systems as a long term solution, as they are rarely portable devices. Furthermore, long term use of a heart-lung machine can damage the blood cells and blood borne products, resulting in post surgical complications such as bleeding, thromboembolism function, and increased risk of infection.

Still another solution for maintaining the existing natural heart as the pumping device involves enveloping a substantial portion of the natural heart, such as the entire left and right ventricles, with a pumping device for rhythmic compression. That is, the exterior wall surfaces of the heart are contacted and the heart walls are compressed to change the volume of the heart and thereby pump blood out of the chambers. Although somewhat effective as a short term treatment, the existing pumping devices have not been suitable for long term use. Typically, with such compression devices, heart walls are concentrically compressed. A vacuum pressure is then needed to overcome cardiac tissue/wall stiffness, so that the compressed heart chambers can return to their original volume and refill with blood. This "active filling" of the chambers with blood limits the ability of the pumping device to respond to the need for adjustments in the blood volume pumped through the natural heart, and can adversely affect the circulation of blood to the coronary arteries. Furthermore, natural heart valves, between the chambers of the heart and leaching into and out of the heart, are quite sensitive to wall distortion and annular distortion. The compressive movement patterns that reduce a chamber's volume and distort the heart walls may not necessarily facilitate valve closure (which can lead to valve leakage).

Therefore, mechanical pumping of the heart, such as through mechanical compression or distortion of the ventricles, must address these issues and concerns in order to establish the efficacy of long term mechanical or mechanically-assisted pumping. Specifically, the ventricles must rapidly and passively refill at low physiologic pressures, and the valve functions must be physiologically adequate. The myocardial blood flow of the heart also must not be impaired by the mechanical device. Still further, the left and right ventricle pressure independence must be maintained within the heart.

The present invention addresses the issues of heart wall stiffness and the need for active refilling by assisting in the bending (i.e., indenting, flattening, twisting, etc.) of the heart walls, rather than concentrically compressing the heart walls. Because of the mechanics of deformation in hearts having proportions typical in heart failure (specifically, wall thickness/chamber radius ratios), the deformation from bending and the subsequent refilling of the heart requires significantly less energy than would the re-stretching of a wall that has been shortened to change the chamber volume a similar amount. The present invention facilitates such desirable heart wall bending and specifically protects the heart wall during such bending.

Another major obstacle with long term use of such pumping devices is the deleterious effect of forceful contact of different parts of the living internal heart surface (endocardium), one against another, due to lack of precise control of wall actuation. In certain cases, this coaptation of endocardium tissue is probably necessary for a device that encompasses both ventricles to produce independent output pressures from the left and right ventricles. However, it can compromise the integrity of the living endothelium.

Mechanical ventricular wall actuation has shown promise, despite the issues noted above. As such, devices have been invented for mechanically assisting the pumping function of the heart, and specifically for externally actuating a heart wall, such as a ventricular wall, to assist in such pumping functions.

Specifically, U.S. Patent No. 5,957,977, which is incorporated herein by reference in its entirety, discloses an actuation system for the natural heart utilizing internal and external support structures. That patent discloses an internal and external framework mounted internally and externally with respect to the natural heart, and an actuator element or activator mounted to the framework for providing cyclical forces to deform one or more walls of the heart, such as the left ventricular wall. The invention of U.S. Patent Application Ser. No. 09/850,554, which is also incorporated herein by reference in its entirety, further adds to the art of U.S. Patent No. 5,957,977 and specifically sets forth various embodiments of activators or actuator elements which are suitable for deforming the heart walls and supplementing and/or providing the pumping function for the natural heart. The actuation provided by such systems uses mechanical elements which engage, act upon and shape a portion of a heart wall. The heart wall is living tissue and, therefore, a concern with such heart wall actuation systems is the prevention of damage to the heart tissue during actuation. Specifically, it is desirable to prevent significant trauma to the outer tissue surfaces of the heart walls acted upon by the actuator elements.

It is therefore an objective of the present invention to further assist in the operation of such systems with the natural heart.

Specifically, it is an objective of the invention to prevent damage to the tissue of the heart, and particularly to prevent damage to the outer heart surface due to abrasion, pinching or other trauma to the heart associated with a heart wall actuation system.

It is still another objective of the present invention to provide long term actuation and assistance for the heart by reducing friction on the heart wall from a heart wall actuation system. It is a further objective of the present invention to encourage the creation of a layer of flexible fibrous or scar tissue on the heart for further protection of the heart with a heart wall actuation system.

These objectives and other objectives are addressed by the invention as described and claimed below. Summary of the Invention

An actuation system for assisting the operation of the natural heart includes a framework for interfacing with the natural heart, an actuator element adapted to be coupled to the framework, and a protective sheath which is configured to extend along the heart wall between the actuator element and a heart wall portion for protecting the heart wall from damage by the action of the actuator element. More specifically, a framework interfaced with the natural heart includes elements which are configured for being anchored to tissue of the heart. An actuator element is configured to extend along a portion of the heart wall exterior surface and indent a portion of the heart wall to effect a reduction in the volume of one or more chambers of the heart and assist its pumping action. .

Such movement along the heart wall and the forces introduced by the actuator element may provide friction, abrasion, pinching, or other trauma to the heart wall, and specifically to the tissue of the outer surface of the heart. The invention utilizes a protective sheath to extend along the heart wall between the actuator element and absorb any abrasion, pinching, or friction forces of the actuator element, to thereby prevent damage to the heart. The protective sheath is flexible and is operable to transmit, to the actuated heart wall portion, a force thereon for indenting the heart wall portion. That is, the forces of the actuator element generally tangent to the heart wall are absorbed, while those forces having components which are normal to the heart wall are transmitted for indenting the heart wall portion and assisting the pumping function of the heart by reducing the volume of one or more heart chambers.

In one embodiment of the invention, the protective sheath is a porous sheath formed by a plurality of interlocking elements formed of an abrasion- resistant material, such as a metal material, or an abrasion-resistant polymer.

The interlocked elements may be utilized to form ring-shaped structures, such as to provide a "chain-mail effect" over the surface of the heart.

In another embodiment of the invention, the protective sheath includes a fabric jacket with a plurality of studs interspersed throughout the fabric. The stud surfaces are generally co-extensive with the surfaces of the fabric.

The studs have rounded surfaces on at least one surface of the fabric, such as the one positioned outwardly from the heart surface and which is engaged by an actuator element. In that way, the protective sheath provides smooth operation of the actuator element against the heart wall, while preventing damage to the heart wall and translating forces from the actuator element to the chamber which is being actuated. The studs are formed of a suitable rugged and wear-resistant material, such as a metal, ceramic, or an abrasion-resistant polymer.

In still another embodiment of the invention, the protective sheath includes a net of woven, abrasion-resistant cords which are intermeshed to form the sheath. The cords forming the net are made of a suitable abrasion- resistant material such as metal, or an abrasion-resistant polymer.

Furtherfeatures and benefits of the invention are set forth hereinbelow in the Detailed Description of Embodiments of the Invention. Brief Description of the Figures

The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and, together with a general description of the invention given below, serve to explain the principles of the invention.

Figure 1 A is a perspective view of one embodiment of the invention illustrated on a natural human heart.

Figures 1 B and 1 C are cross-sectional views which illustrate the embodiment of the invention shown in Figure 1 A with a heart wall actuation system in a relaxed and an actuated state, respectively.

Figure 2A is a perspective view of an alternative embodiment of the invention illustrated on a natural human heart.

Figures 2B and 2C are cross-sectional views which illustrate the alternative embodiment of the invention shown in Figure 2A with a heart wall actuation system in a relaxed and an actuated state, respectively.

Figure 3A is a perspective view of another alternative embodiment of the invention illustrated on a natural human heart.

Figures 3B and 3C are cross-sectional views which illustrate the alternative embodiment of the invention shown in Figure 3A with a heart wall actuation system in a relaxed and an actuated state, respectively. Detailed Description of Embodiments of the Invention

The present invention may best be described in the context of the natural human heart, and accordingly, the heart structure is discussed briefly herein. Furthermore, the present invention is utilized in conjunction with a heart wall actuation system. One such actuation system, is described in U.S.

Patent application Serial No. 09/850,554, which application is incorporated herein by reference in its entirety. Another suitable actuation system for practicing the invention is disclosed in greater detail in U.S. Patent No. 5,957,977, which patent is incorporated herein by reference in its entirety. Other actuation systems may also be suitable. A brief overview of one type of actuation system for practicing the invention and of a framework for such a system is set forth herein.

An understanding of the heart is helpful in understanding the invention, and the heart and various of its components are described herein. Referring now to Figures 1 A, 2A and 3A, a natural human heart 10 is shown in perspective with a portion of a framework of a suitable actuation system and various embodiments of protective sheaths. Heart 10 has a lower portion comprising two chambers, namely a left ventricle 12 and a right ventricle 14, which function primarily to supply the main pumping forces that propel blood through the circulatory system, including the pulmonary system

(lungs) and the rest of the body, respectively. Heart 10 also includes an upper portion having two chambers, a left atrium 16 and a right atrium 18, which primarily serve as entryways to the ventricles 12 or 14, and also assist in moving blood into the ventricles 12 or 14. The interventricular wall or septum of cardiac tissue separating the left and right ventricles 12 and 14, is defined externally by an interventricular groove 20 on the exterior wall of the natural heart 10. The atrioventricular wall of cardiac tissue separating the lower ventricular region from the upper atrial region is defined by atrioventricular groove 22 on the exterior wall of the natural heart 10. The configuration and function of the heart is known to those of ordinary skill in this art.

Generally, the ventricles are in fluid communication with their respective atria through an atrioventricular valve in the interior volume defined by heart 10. More specifically, the left ventricle 12 is in fluid communication with the left atrium 16 through the mitral valve, while the right ventricle 14 is in fluid communication with the right atrium 18 through the tricuspid valve. Generally, the ventricles are in fluid communication with the circulatory system (i.e., the pulmonary and peripheral circulatory system) through semilunar valves. More specifically, the left ventricle 12 is in fluid communication with the aorta 26 of the peripheral circulatory system, through the aortic valve, while the right ventricle 14 is in fluid communication with the pulmonary artery 28 of the pulmonary, circulatory system through the pulmonic or pulmonary valve. The heart basically acts like a pump. The left and right ventricles are separate, but share a common wall, or septum. The left ventricle has thicker walls and pumps blood into the systemic circulation of the body. The pumping action of the left ventricle is more forceful than that of the right ventricle, and the associated pressure achieved within the left ventricle is also greater than in the right ventricle. The right ventricle pumps blood into the pulmonary circulation, including the lungs. During operation, the left ventricle fills with blood in the portion of the cardiac cycle referred to as diastole. The left ventricle then ejects any blood in the part of the cardiac cycle referred to as systole. The volume of the left ventricle is largest during diastole, and smallest during systole. The heart chambers, particularly the ventricles, change in volume during pumping.

By way of a non-limiting example, the present invention is discussed in terms of use with a heart wall actuation system to assist in the actuation and operation of the left ventricular portion of the heart 10. However, it is noted that the present invention can also be used for the actuation and operation of other portions of the natural heart 10, such as the individual atria, the right ventricular portion of the heart 10, or simultaneously both atria or both ventricles. The present invention protects the portion of the heart engaged by an actuation system.

In accordance with illustrating an example of use of the invention with the left ventricular portion of the heart, a framework is discussed which positions one possible actuator system on the exterior surface or epicardium of the left ventricle. The invention may also be used on other surfaces of the heart. Also, other actuation systems may be used with the invention other than the one illustrated in the drawings.

Part of the framework is illustrated in Figures 1A, 2A, and 3A by reference numeral 70, which refers to an external component or yoke of the framework. The framework also includes internal framework elements (not shown) including an internal stint to which the external yoke or external framework element 70 is fixed by transmural cords which extend through walls of the heart. The internal stint is sized and configured for placement within the interior volume of the natural heart 10, generally alongside the right side of the interventricular septum. The stint also includes at least two separate ring structures (not shown) for positioning proximate the valve annuli of the left side of the heart. Further details of suitable frameworks are set forth in U.S. Patent No. 5,957,977, and pending U.S. Patent Application Serial No. 09/850,554. As illustrated in Figures 1 A, 2A, and 3A, the framework also includes the external yoke 70 which is configured for placement around a portion of the exterior surface or epicardium of a natural heart 10. The generally stirrup-shaped yoke 70 in the illustrated embodiment restricts free motion of the natural heart 10 so that the natural heart 10 can be actuated and assisted. Yoke 70 also acts as an anchor for an appropriate actuator element or system for use with the invention. In one embodiment, the yoke 70 is between about 1 and 2 cm wide and includes a semi-rigid collar portion, preferably made of either a solid polymer of appropriate mechanical behavior, such as polypropylene or polyacetal, or a composite of metal (stainless steel or pure titanium) band or coil spring elements, polymer fabric and fiber (e.g. polyester knit) and soft elastomer, for providing rigidity to the yoke 70. Additionally, the yoke 70 may include a gel-filled cushion portion 80 that is positioned immediately adjacent the exterior surface (epicardium) of the natural heart 10 for providing equalized pressure over the irregularities in the epicardial surface of the heart 10, and any of the coronary arteries 30 within a region under the yoke 70. Preferably, the yoke 70 is sized and configured for placement adjacent at least a portion of the atrioventricular groove 22, and simultaneously adjacent at least a portion of the anterior and posterior portions of the interventricular groove 20, and most preferably, adjacent at least a substantial portion of the anterior and posterior portion of the interventricular groove 20, as shown in Figures 1A, 2A, and 3A.

General alignment of the yoke 70 with interior framework elements is maintained by at least one transmural cord (not shown), and preferably, a plurality of cords that penetrate the walls of the natural heart 10 and connect to the internal stint and one or more of the internal rings, as noted above and discussed in U.S. Patent No. 5,957,977.

Referring now to Figure 1A, an actuation system 82 is illustrated for assisting the operation of the natural heart 10. The actuation system 82 incorporates a framework for interfacing with the natural heart, as discussed above. One visual external element of a suitable framework is the yoke 70, as illustrated in Figure 1A. Yoke 70 is anchored to tissue of the heart, such as through an internal framework element or elements, as discussed above. The yoke element 70 is anchored in position on heart 10 to provide support for an actuator device or element. As illustrated in the figures, the actuation system of the invention, and particularly the protective sheath 84, are shown coupled to the left ventricle of the heart. However, as will be understood by a person of ordinary skill in the art, the invention may be utilized with other chambers of the heart, such as the left atrium, or the right side of the heart, including the right atrium and/or the right ventricle. Therefore, the invention is shown positioned for the purposes of illustration only, and its illustrated position is not meant to be limiting to the usefulness of the invention.

For actuating a wall of the heart, such as to cyclically deform or shape the wall of the heart, change the volume of a heart chamber, and assist in the pumping action, the actuator system includes an actuator element or device which is adapted to be coupled to the framework, such as yoke 70. One possible actuator element 86 is shown in the Figures, but is not meant to be limiting. The actuator element 86 is configured for extending along, or proximate to, a portion of the heart wall exterior surface, such as the exterior surface 96 of the left ventricle. Actuator element 86 is operable for indenting or shaping the portion of the heart wall to effect a reduction in the volume of the heart and thereby assist in the pumping of blood through the heart. In the illustrated embodiment, the actuator element 86 comprises an actuator band extending along a portion of the heart wall and selectively movable between a relaxed state and an actuated state, as illustrated in Figures 1B and 1 C, respectively. When in the actuated state, the band 86 assumes a predetermined shape, as illustrated in Figure 1C, and thereby indents the protective sheath 84 of the invention, and indents a portion of the heart wall underlying the protective sheath to affect a reduction in the volume of the heart for a particular heart chamber (e.g., the left ventricle). Actuator band 86 includes a plurality of juxtaposed blocks 88 configured to be drawn together and to cooperate with each other, when drawn together, to assume a predetermined shape. In the Figures, and particularly Figures 1C, 2C, and 3C, the band is shown to take a generally flat shape in contrast to the relaxed curved shape which follows the natural curves of the heart. However, the band might be made to take various shapes when actuated, as shown in U.S. Patent Application Serial No. 09/850,554. For actuating the element 86, the blocks include a passage 90 formed therethrough, made up of individual passages through the respective blocks 88. A cable structure 92 extends through the passage and is coupled at one end to an anchor point, such as to the framework element, or yoke 70. Drawing cable 92 through the passage 90 draws the blocks together so that the blocks cooperate with each other as illustrated in Figure 1 C, to assume the desired predetermined shape of the actuated band. The band 86 acts on the heart wall and indents the heart wall to effect a reduction in volume of the heart chamber. For example, band 86 may provide an inward force on the heart wall. As shown between Figures 1B and 1C, the actuator blocks 88 also slide or move along the heart wall surface in the actuated state. This presents a fixation force on the heart wall, generally normal to the wall surface 96. Such an actuator system is illustrated in greater detail in U.S. Patent Application, Serial No. 09/850,554.

In accordance with another aspect of the present invention, protective sheath 84 is configured to extend along a portion of the heart wall, such as the outer wall of the left ventricle, as illustrated in the figures. The protective sheath 84 extends along the wall and is positioned between the actuator element 86 and the heart wall surface 96 for protecting the heart wall surface 96 from damage by the actuator element. The protective sheath is flexible, and is operable to transmit, to the heart wall portion, a force thereon by the actuator element for indenting the heart wall portion. More specifically, in the illustrated embodiment of the actuator element 86, the blocks 88 move against heart wall portion 94 as the actuator element moves between a relaxed and actuated position. The heart wall portion 94 and tissue associated therewith, are forcibly indented and deformed due to the action of the actuator element 86. Furthermore, friction exists between heart wall portion 94 (i.e., surface 96) and the moving blocks 88. The protective sheath 86 protects the tissue of the heart wall portion 94 to prevent damage of that tissue. Simultaneously, the forces for shaping and deforming the wall portion

94 are transmitted through the flexible protective sheath 84. The sheath provides a paving feature which absorbs the friction of the movement of the actuator elements, such as the individual blocks 88, and protects the heart surface 96 from abrasion, pinching, or other trauma associated with the action of the actuator element 86. For example, pinching of the heart wall tissue may be a specific concern with the actuator element 86 illustrated herein.

The protective sheath also helps to blunt any trauma to the heart tissue caused by the actuator element and helps spread the indenting forces smoothly over the heart wall surface 96.

In one embodiment of the invention, the protective sheath 84 is generally porous and may include openings which encourage the ingrowth of a layer of flexible fibrous, or scar tissue, which intermeshes with sheath 84 and extends the overall protective effect of the invention. Figures 1A-1 C illustrate one particular embodiment of the invention. Specifically, the protective sheath 84 includes a plurality of interlocked elements 100. As illustrated in Figure 1A, the interlocked elements 100 essentially form individual ring structures, as illustrated by reference numeral 102. In such an embodiment, the protective sheath 84 resembles "chain- mail" armor which may move freely in all directions so that the heart may be actuated readily in all directions.

The protective sheath 84 may be held in position on the heart with tissue adhesives, sutures, or other means commonly used for tissue-to- prosthesis fixation. That is, it may be just wrapped around the heart.

Alternatively, the sheath 84 may be fixed to a framework element, such as yoke 70 and/or to the actuator element 86. The material making up the interlocked elements 100 may be formed of a suitable metal, such as stainless steel 316 or CP titanium, for providing low friction and wear resistance. An alternative material for the interlocked elements 100 might include a ceramic, highly abrasion-resistant polymer, such as polyacetal (e.g., a material often referred to as Delrin™) or polyethylene, particularly ultra-high molecular weight polyethylene, or UHMWFE. Other materials may be nickel-titanium alloys or other shape memory components, such as, for example, Nitinol™. Alternatively, the interlocked elements might be formed of a combination of such materials wherein alternating elements are made of different materials.

Figures 2A, 2B, and 2C illustrate another embodiment of the invention, and are illustrated similarly to Figures 1A-1C. That is, Figure 2A shows the alternative embodiment of the protective sheath mounted on a human heart with a suitable framework. Figures 2B and 2C illustrate one possible actuator element to be utilized with the protective sheath, in both a relaxed and actuated position, respectively. Similar reference numerals are utilized for similar elements previously described in Figures 1A-1C.

Protective sheath 86a includes a net of woven or knit, abrasion- resistant cords or threads. As illustrated in Figure 2B, for example, transverse cords 104, cooperate with longitudinal cords 106 to form the net. The net might be woven or knitted in various other suitable ways known to those of ordinary skill in the art, and the embodiment of the invention is not limited to the woven structure illustrated in the drawings. Protective sheath 86a provides an abrasion-resistant net for protecting the tissue of the heart, as discussed above, while providing the translation of necessary forces to the heart from the actuation system. The actuator element 86, and particularly the blocks 88 may readily move on the net 86a for forming and shaping the heart wall portion 94. As noted, the woven net 86a provides a paving action and absorbs friction of movement of the blocks 88 while protecting the heart surface 96 from abrasion, pinching, and other trauma.

In one embodiment of the invention, the net 86a is formed of cords 104, 106 which are made of an abrasion resistant material, such as a suitable metal, including stainless steel 316 or CP titanium, nickel-titanium alloys, ceramics, or shape memory materials. Another suitable material for the cords 104, 106 forming the protective net 86a is an abrasion resistant polymer, such as linearly crystalline polyethylene, sometimes referred to by the trademark Spectra™. A combination of the various materials might also be used.

In one embodiment, the cables or cords (e.g. cords 106) on the actuator-facing surface, ortheir component fibers, are oriented parallel to the direction of tangential motion of the actuator element 86, such as the motion of blocks 88. For example, referring to Figures 2B and 2C, the block 88 would generally move tangentially in the direction of arrows 89 when actuated. With the cords 106 oriented generally parallel with that direction, friction may be reduced to make a smoother surface. This may, in turn, reduce both material damage from wear and energy loss from friction. The cords may be so oriented using available textile design and manufacturing techniques as known to those of ordinary skill in the art. While the actuator 86 of the Figures shows one possible embodiment, other embodiments might have elements moving in other tangential directions than direction 89. In accordance with the invention, other cords, such as cords 104, might be oriented generally parallel to such other tangential motion.

Figures 3A, 3B, and 3C illustrate another alternative embodiment of the invention, and like reference numerals are utilized for like elements, as discussed above. A protective sheath 86b includes a fabric jacket 108, with a plurality of studs 110 interspersed throughout the fabric jacket 108. Referring to Figures 3B and 3C, the studs 110 have stud surfaces 112 on either side thereof, and the stud surfaces are generally co-extensive with surfaces of the fabric 108. In that way, the combination of fabric jacket and studs forms an overall protective sheath 86b. In accordance with one aspect of the present invention, the surfaces 112a of the studs, which are positioned away from the heart, are rounded. With the outer rounded surfaces 112a, the blocks 88 of the actuator element 86 slide freely over the protective sheath 84b and the sheath prevents damage to the heart tissue associated with the actuation of the heart wall.

Suitable materials for the studs include suitable metals, such as stainless steel 316 or CP titanium. A ceramic, such as pyrolytic carbon would also be suitable. Furthermore, a wear-resistant polymer, such as a polyacetal (e.g., Delrin™, as noted above) or ultra-high molecular weight polyethylene (UHMWPE) may also be utilized.

The fabric jacket may be formed of a biocompatible material, such as a woven, knit, or braided material of polyester, linearly crystalline polyethylene (Spectra™), or polytetrafluoroethylene. Alternatively, an absorbable polymeric fabric, such as an oxidized cellulose or polyglycolic acid might be utilized.

The protective sheath 84b operates similarly to the other embodiments of the protective sheath discussed above to translate forces in motion of the actuator element to heart wall portion 94 without damaging the tissue of heart surface 96.

The present invention provides a significant benefit when utilized with heart wall actuating elements and systems by providing a protective paving structure which allows elements of the heart wall actuating system to slide on the surface of the heart in the directions which are generally tangent to the surface 96 of the heart wall and the surface created by the protective sheath. Simultaneously, the protective sheath is flexible, and is operable to transmit any translational or inward movement of the actuator elements in directions which have force components generally normal to the heart surface 96 and normal to the protective sheath, such as in the direction of reference arrow

120 in Figure 1 B.

The protective sheath of the invention may be anchored to the framework, such as framework element 70 for providing the desired protection of the heart wall which is being actuated. Alternatively, as noted above, the protective sheath could be individually coupled, such as by adhesive or sutures to the heart wall.

The porosity of the protective sheath is a desirable characteristic, as it may allow and/or encourage ingrowth of a layer of a flexible, fibrous or scar tissue with the protective sheath which expands and extends the protective effect of the invention. However, the growth of such a layer is not critical to the invention, as the invention alone will provide the desired protection of the actuated heart wall.

While the present invention has been illustrated by the description of the embodiments thereof, and while the embodiments have been described in considerable detail, it is not the intention of the applicant to restrict or in

any way limit the scope of the appended claims to such detail. Additional advantages and modifications will readily appear to those skilled in the art. Therefore, the invention in its broader aspects is not limited to the specific details representative apparatus and method, and illustrative examples shown and described. Accordingly, departures may be made from such details without departure from the spirit or scope of applicant's general inventive concept.

What is claimed is:

Claims

Claims:
1. An actuation system for assisting the operation of the natural heart, the actuation system comprising: an actuator element configured for extending proximate a portion of a heart wall exterior surface and operable for indenting the portion of the heart wall to effect a reduction in the volume of the heart; a protective sheath configured to extend along the heart wall between the actuator element and the heart wall portion for protecting the heart wall portion from damage by the actuator element; the protective sheath being flexible and operable to transmit, to the heart wall portion, a force thereon by the actuator element for indenting the heart wall portion.
2. The actuation system of claim 1 further comprising a framework for interfacing with the heart and including elements configured for being anchored to the heart.
3. The actuation system of claim 1 wherein the protective sheath is porous.
4. The actuation system of claim 1 wherein the protective sheath comprises: a plurality of interlocked elements.
5. The actuation system of claim 4 wherein interlocked elements of the plurality are formed of at least one of stainless steel, titanium, an abrasion- resistant polymer, a ceramic, nickel-titanium alloys, shape memory materials, and a combination of same.
6. The actuation system of claim 1 wherein the interlocked elements form ring-shaped structures.
7. The actuation system of claim 1 wherein the protective sheath comprises: a fabric jacket; a plurality of studs interspersed throughout the fabric and having stud surfaces generally coextensive with surfaces of the fabric.
8. The actuation system of claim 7 wherein said studs have rounded surfaces on at least one surface of the fabric.
9. The actuation system of claim 7 wherein the studs are formed of at least one of stainless steel, titanium, a ceramic, an abrasion-resistant polymer and a combination of same.
10. The actuation system of claim 7 wherein the fabric jacket is formed of at least one of a polyester, PTFE, a cellulose, polyethylene, and polyglycolic acid.
11. Trie actuation system of claim 1 wherein the protective sheath comprises: a net of woven, abrasion-resistant cords.
12. The actuation system of claim 11 wherein the cords are formed of at least one of stainless steel, titanium, an abrasion-resistant polymer, a ceramic, nickel-titanium alloys, shape memory material, and a combination of same.
13. The actuation system of claim 1 wherein the actuator element comprises: an actuator band extending along a portion of a heart wall, the actuator band being selectively movable between an actuated state and a relaxed state and operable, when in the actuated state, to assume a predetermined shape and thereby indent the protective sheath and a portion of the heart wall to effect a reduction in the volume of the heart.
14. The actuation system of claim 13 wherein the actuator band includes a plurality of juxtaposed blocks configured to be drawn together and to cooperate with each other, when drawn together, to assume the predetermined shape.
15. The actuation system of claim 7 wherein at least some of the cords extend in a direction; the actuator element moving in a direction generally parallel to said cord direction.
16. The actuation system of claim 2 wherein said protective sheath is anchored to said framework.
17. The actuation system of claim 1 wherein said protective sheath is anchored to said actuator element.
18. The actuation system of claim 1 wherein said protective sheath is configured for being anchored to tissue of a heart.
19. The actuation system of claim 2 wherein the actuator element is coupled to the framework.
20. A method for assisting the operation of the natural heart, the method comprising: positioning an actuator element to extend along a portion of a heart
wall exterior surface; positioning a flexible protective sheath along the heart wall between the actuator element and the heart wall portion for protecting the heart wall portion from damage; indenting the sheath and portion of the heart wall to effect a reduction in the volume of the heart.
21. The method of claim 20 further comprising anchoring a framework to tissue of a natural heart and coupling the actuator element to the framework.
22. The method of claim 21 further comprising anchoring a framework having at least one internal element coupled to tissue inside of the heart and at least one external element coupled to an outside surface of the heart.
23. The method of claim 20 further comprising positioning a protective sheath having a plurality of interlocked rings along the heart wall.
24. The method of claim 20 further comprising positioning, along the heart wall, a protective sheath having a fabric jacket and plurality of studs interspersed throughout the fabric and having stud surfaces generally coextensive with surfaces of the fabric.
25. The method of claim 20 further comprising positioning a protective sheath including having a net of woven, abrasion-resistant cords along the heart wall.
26. The method of claim 20 further comprising positioning an actuator band to extend along a portion of a heart wall, and manipulating the actuator band so the band takes a predetermined shape and indent the protective sheath and a portion of the heart wall.
27. The method of claim 26 wherein the actuator band includes a plurality of juxtaposed blocks, the method further comprising drawing the blocks together to make the band assume the predetermined shape.
28. The method of claim 25 wherein at least some of the cords extend in a direction, the method comprising indenting the sheath and heart wall portion by moving the actuator element in a direction generally parallel to the cord direction.
29. The method of claim 20 further comprising anchoring the protective sheath to tissue of the heart.
30. The method of claim 21 further comprising anchoring the protective sheath to the framework.
31. The method of claim 20 further comprising anchoring the protective sheath to the actuator element.
PCT/US2003/022054 2002-07-18 2003-07-16 A protective sheath apparatus and method for use with a heart wall actuation system for the natural heart WO2004008941A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10197973 US20040015041A1 (en) 2002-07-18 2002-07-18 Protective sheath apparatus and method for use with a heart wall actuation system for the natural heart
US10/197,973 2002-07-18

Publications (2)

Publication Number Publication Date
WO2004008941A2 true true WO2004008941A2 (en) 2004-01-29
WO2004008941A3 true WO2004008941A3 (en) 2004-07-08

Family

ID=30443031

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/022054 WO2004008941A3 (en) 2002-07-18 2003-07-16 A protective sheath apparatus and method for use with a heart wall actuation system for the natural heart

Country Status (2)

Country Link
US (2) US20040015041A1 (en)
WO (1) WO2004008941A3 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9492270B2 (en) 2007-09-12 2016-11-15 Alan Joel Melvin Medical device and tension member for use in a subject

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6050936A (en) 1997-01-02 2000-04-18 Myocor, Inc. Heart wall tension reduction apparatus
US6406420B1 (en) * 1997-01-02 2002-06-18 Myocor, Inc. Methods and devices for improving cardiac function in hearts
US6332893B1 (en) * 1997-12-17 2001-12-25 Myocor, Inc. Valve to myocardium tension members device and method
US6260552B1 (en) * 1998-07-29 2001-07-17 Myocor, Inc. Transventricular implant tools and devices
US6464628B1 (en) * 1999-08-12 2002-10-15 Obtech Medical Ag Mechanical anal incontinence
DE60133592D1 (en) * 2000-02-10 2008-05-21 Potencia Medical Ag Mechanical device for impotence treatment
EP1253880B1 (en) 2000-02-10 2005-09-14 Potencia Medical AG Controlled urinary incontinence treatment
US6471635B1 (en) * 2000-02-10 2002-10-29 Obtech Medical Ag Anal incontinence disease treatment with controlled wireless energy supply
EP1255513B1 (en) * 2000-02-14 2005-05-25 Potencia Medical AG Penile prosthesis
DE60119081D1 (en) * 2000-02-14 2006-06-01 Potencia Medical Ag Male impotentzprothesevorrichtung with wireless energy supply
US6537198B1 (en) * 2000-03-21 2003-03-25 Myocor, Inc. Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly
US6616684B1 (en) * 2000-10-06 2003-09-09 Myocor, Inc. Endovascular splinting devices and methods
US6723038B1 (en) * 2000-10-06 2004-04-20 Myocor, Inc. Methods and devices for improving mitral valve function
US7174896B1 (en) * 2002-01-07 2007-02-13 Paracor Medical, Inc. Method and apparatus for supporting a heart
US8506624B2 (en) 2002-01-09 2013-08-13 Edwards Lifesciences, Llc Devices and methods for heart valve treatment
US6764510B2 (en) * 2002-01-09 2004-07-20 Myocor, Inc. Devices and methods for heart valve treatment
US20030233022A1 (en) * 2002-06-12 2003-12-18 Vidlund Robert M. Devices and methods for heart valve treatment
US7247134B2 (en) * 2002-11-12 2007-07-24 Myocor, Inc. Devices and methods for heart valve treatment
US7112219B2 (en) * 2002-11-12 2006-09-26 Myocor, Inc. Devices and methods for heart valve treatment
WO2005079388A3 (en) * 2004-02-13 2006-04-06 Mark T Byrne A coupling device enabled by mechanical continuity of cellular scaffolding across tissue boundaries
US8007531B2 (en) * 2004-08-06 2011-08-30 Frank Robert E Implantable prosthesis for positioning and supporting a breast implant
US7476249B2 (en) * 2004-08-06 2009-01-13 Frank Robert E Implantable prosthesis for positioning and supporting a breast implant
US20060247491A1 (en) * 2005-04-27 2006-11-02 Vidlund Robert M Devices and methods for heart valve treatment
US8231517B2 (en) * 2005-12-31 2012-07-31 John W Royalty Stabilization for electromagnetic biventricular assist device
WO2007098066A3 (en) * 2006-02-16 2008-05-29 Qi Liao Polymeric heart restraint
WO2007123997A3 (en) 2006-04-19 2008-04-03 Beth Israel Hospital Pericardial reinforcement device
US8075471B2 (en) * 2006-07-12 2011-12-13 Allegheny-Singer Research Institute Apical torsion device for cardiac assist
US8206349B2 (en) * 2007-03-01 2012-06-26 Medtronic Xomed, Inc. Systems and methods for biofilm removal, including a biofilm removal endoscope for use therewith
WO2009076209A1 (en) * 2007-12-05 2009-06-18 Surgical Energetics, Inc A bolster for securing a septal splint to a cardiac wall, a method of use thereof, and a system including the same
WO2009096852A1 (en) * 2008-01-28 2009-08-06 Milux Holding Sa An implantable drainage device
CN104323877A (en) * 2008-01-29 2015-02-04 米卢克斯控股股份有限公司 Device for treating gastroesophageal reflux disease
WO2010042019A1 (en) * 2008-10-10 2010-04-15 Milux Holding Sa Heart help device, system, and method
WO2010042032A1 (en) * 2008-10-10 2010-04-15 Milux Holding S.A. Fastening means for implantable medcial control assembly
EP3120896A1 (en) 2008-10-10 2017-01-25 Kirk Promotion LTD. A system, an apparatus, and a method for treating a sexual dysfunctional female patient
EP2349170A4 (en) 2008-10-10 2012-05-09 Milux Holding Sa Apparatus, system and operation method for the treatment of female sexual dysfunction
WO2010042014A1 (en) * 2008-10-10 2010-04-15 Milux Holding Sa Heart help device, system, and method
US20110196486A1 (en) * 2008-10-10 2011-08-11 Milux Holdings SA Heart help device, system, and method
US20110015473A1 (en) * 2009-07-17 2011-01-20 Teslux Holdings S.A. Vaginal operation method for the treatment of urinary incontinence in women
US20140357938A1 (en) * 2011-12-01 2014-12-04 The Trustees Of The University Of Pennsylvania Non-blood contacting mechanical device that improves heart function after injury
EP3185797A1 (en) * 2014-08-25 2017-07-05 Bioventrix, Inc. Tissue protecting devices for treatment of congestive heart failure and other conditions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5702343A (en) * 1996-10-02 1997-12-30 Acorn Medical, Inc. Cardiac reinforcement device
US20020007216A1 (en) * 1996-01-02 2002-01-17 Melvin David Boyd Heart wall actuation device for the natural heart
US6684404B2 (en) * 2000-08-16 2004-02-03 Second Chance Body Armor, Inc. Multi-component stab and ballistic resistant garment and method

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2826193A (en) * 1956-08-01 1958-03-11 Vineberg Heart Foundation Cardiac resuscitation device
US3053249A (en) * 1959-08-25 1962-09-11 Gorman Rupp Ind Inc Cardiac massage apparatus
FR92798E (en) * 1966-09-05 1968-12-27 Rhone Poulenc Sa New prosthesis heart support and manufacturing.
US3455298A (en) * 1967-04-10 1969-07-15 George L Anstadt Instrument for direct mechanical cardiac massage
US3590815A (en) * 1969-01-07 1971-07-06 Peter Shiff Portable mechanical ventricular assistance device
US3613672A (en) * 1969-07-09 1971-10-19 Peter Schiff Mechanical ventricular assistance cup
US3668708A (en) * 1969-12-23 1972-06-13 North American Rockwell Artificial heart
US3713439A (en) * 1970-03-02 1973-01-30 J Cabezudo Massage envelope belt with adjusting dispositives for vibrators and mobilizers
US3827426A (en) * 1971-07-16 1974-08-06 P Sawyer Prosthetic pump
FR2250692B1 (en) * 1973-11-09 1978-02-24 Automatisme & Technique
US3999220A (en) * 1976-04-22 1976-12-28 Keltner Raymond O Air-cushioned protective gear
US4192293A (en) * 1978-09-05 1980-03-11 Manfred Asrican Cardiac assist device
US4228066A (en) 1979-04-12 1980-10-14 Exxon Research & Engineering Co. Stabilized polymer compositions
US4621617A (en) * 1981-06-29 1986-11-11 Sharma Devendra N Electro-magnetically controlled artificial heart device for compressing cardiac muscle
DE3307211A1 (en) * 1982-03-03 1983-09-08 Roberto Parravicini An implantable device for assisting the activity of the myocardium
US4690134A (en) * 1985-07-01 1987-09-01 Snyders Robert V Ventricular assist device
FR2591489B1 (en) * 1985-12-16 1988-03-25 Aerospatiale The total heart prosthesis comprising two pumping modules subsequently assembled by a functional bond.
US4846831A (en) * 1988-04-27 1989-07-11 Skillin David E Manual back-up drive for artificial heart
US5139517A (en) * 1989-11-08 1992-08-18 Corral David F Orthotopic intraventricular heart pump
US5358519A (en) * 1989-12-06 1994-10-25 Medtronic, Inc. Muscle control and monitoring system
US5131905A (en) * 1990-07-16 1992-07-21 Grooters Ronald K External cardiac assist device
US5119804A (en) * 1990-11-19 1992-06-09 Anstadt George L Heart massage apparatus
US5109843A (en) * 1990-11-30 1992-05-05 University Of Cincinnati Extra to-intracorporeal power supply
US5370685A (en) * 1991-07-16 1994-12-06 Stanford Surgical Technologies, Inc. Endovascular aortic valve replacement
JP3393383B2 (en) * 1992-01-21 2003-04-07 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ Septal defect closure device
US5258021A (en) * 1992-01-27 1993-11-02 Duran Carlos G Sigmoid valve annuloplasty ring
US5201880A (en) * 1992-01-27 1993-04-13 Pioneering Technologies, Inc. Mitral and tricuspid annuloplasty rings
US5383840A (en) * 1992-07-28 1995-01-24 Vascor, Inc. Biocompatible ventricular assist and arrhythmia control device including cardiac compression band-stay-pad assembly
US5256132A (en) * 1992-08-17 1993-10-26 Snyders Robert V Cardiac assist envelope for endoscopic application
US5533958A (en) * 1993-06-17 1996-07-09 Wilk; Peter J. Intrapericardial assist device and associated method
US5487760A (en) * 1994-03-08 1996-01-30 Ats Medical, Inc. Heart valve prosthesis incorporating electronic sensing, monitoring and/or pacing circuitry
US5713954A (en) * 1995-06-13 1998-02-03 Abiomed R&D, Inc. Extra cardiac ventricular assist device
US5800528A (en) * 1995-06-13 1998-09-01 Abiomed R & D, Inc. Passive girdle for heart ventricle for therapeutic aid to patients having ventricular dilatation
US6520904B1 (en) 1996-01-02 2003-02-18 The University Of Cincinnati Device and method for restructuring heart chamber geometry
US5957977A (en) * 1996-01-02 1999-09-28 University Of Cincinnati Activation device for the natural heart including internal and external support structures
US6050936A (en) * 1997-01-02 2000-04-18 Myocor, Inc. Heart wall tension reduction apparatus
US6332893B1 (en) * 1997-12-17 2001-12-25 Myocor, Inc. Valve to myocardium tension members device and method
US6547821B1 (en) * 1998-07-16 2003-04-15 Cardiothoracic Systems, Inc. Surgical procedures and devices for increasing cardiac output of the heart
US6183411B1 (en) * 1998-09-21 2001-02-06 Myocor, Inc. External stress reduction device and method
CA2402504A1 (en) 2000-03-10 2001-09-20 Paracor Surgical, Inc. Expandable cardiac harness for treating congestive heart failure
WO2001091667A9 (en) 2000-05-31 2002-07-04 Cardioclasp Inc Devices and methods for assisting natural heart function
US6808483B1 (en) * 2000-10-03 2004-10-26 Paul A. Spence Implantable heart assist devices and methods

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020007216A1 (en) * 1996-01-02 2002-01-17 Melvin David Boyd Heart wall actuation device for the natural heart
US5702343A (en) * 1996-10-02 1997-12-30 Acorn Medical, Inc. Cardiac reinforcement device
US6684404B2 (en) * 2000-08-16 2004-02-03 Second Chance Body Armor, Inc. Multi-component stab and ballistic resistant garment and method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9492270B2 (en) 2007-09-12 2016-11-15 Alan Joel Melvin Medical device and tension member for use in a subject

Also Published As

Publication number Publication date Type
US20040015041A1 (en) 2004-01-22 application
US7662085B2 (en) 2010-02-16 grant
US20060009676A1 (en) 2006-01-12 application
WO2004008941A3 (en) 2004-07-08 application

Similar Documents

Publication Publication Date Title
US5423886A (en) Cyclically deformable haemocompatible and biocompatible devices coated with biocompatible carbonaceous material
US4666443A (en) Biventricular circulatory assist system and method
US6887192B1 (en) Heart support to prevent ventricular remodeling
US4979936A (en) Autologous biologic pump motor
US6214047B1 (en) Article and method for coupling muscle to a prosthetic device
US5456715A (en) Implantable mechanical system for assisting blood circulation
US20030158570A1 (en) Endoventicular device for the treatment and correction of cardiomyopathies
EP0601804A1 (en) Medical implants of biocompatible low modulus titanium alloy
US20050177227A1 (en) Method for producing an aortic or mitral heart valve prosthesis and resulting aortic or mitral heart valve
US6682476B2 (en) Cardiac disease treatment and device
US5139515A (en) Ascending aortic prosthesis
US20060195004A1 (en) Minimally invasive transvalvular ventricular assist device
US20100030014A1 (en) Intracardiac device for restoring the functional elasticity of the cardiac structures, holding tool for the intracardiac device, and method for implantation of the intracardiac device in the heart
US6604529B2 (en) External electromagnetic system for assisting systolic and diastolic ventricular function, and method therefor
US4376312A (en) Hydraulically actuated cardiac prosthesis
US6984201B2 (en) Blood circulation assistance device
US4536893A (en) Implant device for substaining the activity of the myocardium
US4369530A (en) Hydraulically actuated cardiac prosthesis and method of actuation
US6994666B2 (en) Non-porous smooth ventricular assist device conduit
US6146325A (en) Ventricular assist device
US6723041B2 (en) Device for treating heart failure
DeBakey Left ventricular bypass pump for cardiac assistance: clinical experience
US20040167375A1 (en) Cardiac assist device with electroactive polymers
US20060025858A1 (en) Mitral valve ring for treatment of mitral valve regurgitation
US20020173742A1 (en) Methods and apparatus for reducing localized circulatory system pressure

Legal Events

Date Code Title Description
AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
WWW Wipo information: withdrawn in national office

Country of ref document: JP

NENP Non-entry into the national phase in:

Ref country code: JP